Year archive

Simcere Pharmaceutical Group Limited — 2026 filings

All 37 regulatory filings released by Simcere Pharmaceutical Group Limited (S2P) in 2026, sourced directly from the official regulator.

37 Filings

2026 Period

2026 filings (37)

Filing	Released	Lang
Next Day Disclosure Return Transaction in Own Shares	2026-05-15	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-14	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-06	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0613 (LRRC15 ANTIBODY-DRUG CONJUGATE) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2026-05-06	English
Next Day Disclosure Return Regulatory Filings	2026-05-05	English
Next Day Disclosure Return Regulatory Filings	2026-05-04	English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION (NDA) OF RADEMIKIBART WAS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2026-04-30	English
NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF ANNUAL REPORT 2025 AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2026-04-28	English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF ANNUAL REPORT 2025 AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT Report Publication Announcement	2026-04-28	English
2025 Environmental, Social and Governance Report Regulatory Filings	2026-04-28	English
2025 ANNUAL REPORT Regulatory Filings	2026-04-28	English
VOLUNTARY ANNOUNCEMENT - LATEST DEVELOPMENTS OF RADEMIKIBART Regulatory Filings	2026-04-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Share Issue/Capital Change	2026-04-02	English
GRANT OF AWARDS UNDER THE 2021 RSU SCHEME Share Issue/Capital Change	2026-03-26	English
Next Day Disclosure Return Transaction in Own Shares	2026-03-26	English
CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF ENTIRE EQUITY INTEREST IN THE TARGET COMPANY M&A Activity	2026-03-25	English
CHANGE OF JOINT COMPANY SECRETARY Board/Management Information	2026-03-25	English
PROPOSED AMENDMENTS TO THE EXISTING ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW ARTICLES OF ASSOCIATION Governance Information	2026-03-25	English
CHANGE OF CHIEF EXECUTIVE OFFICER Board/Management Information	2026-03-25	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 Earnings Release FY 2025	2026-03-25	English
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2025 Notice of Dividend Amount	2026-03-25	English
VOLUNTARY ANNOUNCEMENT - SIM0237 PHASE I/II CLINICAL STUDY DATA IN NON-MUSCLE-INVASIVE BLADDER CANCER PRESENTED AT THE EUROPEAN ASSOCIATION OF UROLOGY ANNUAL CONGRESS 2026 Regulatory Filings	2026-03-17	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-04	English
PROFIT ALERT Earnings Release FY 2025	2026-02-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Regulatory Filings	2026-02-04	English
VOLUNTARY ANNOUNCEMENT - RECEIPT OF RECENT MILESTONE PAYMENT UNDER SIM0500 OPTION TO LICENSE AGREEMENT WITH ABBVIE Regulatory Filings	2026-02-03	English
Boehringer Ingelheim und Simcere gehen Partnerschaft ein, um eine dual-zielgerichtete Antikorperbehandlung zur Behandlung von entzundlichen Darmerkrankungen voranzutreiben Regulatory Filings	2026-01-28	German
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease Regulatory Filings	2026-01-27	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO EXCLUSIVE LICENSING AGREEMENT WITH BOEHRINGER INGELHEIM IN RELATION TO SIM0709 (TL1A/IL23P19 BISPECIFIC ANTIBODY) Regulatory Filings	2026-01-27	English
Next Day Disclosure Return Transaction in Own Shares	2026-01-22	English
Next Day Disclosure Return Transaction in Own Shares	2026-01-20	English
Next Day Disclosure Return Transaction in Own Shares	2026-01-16	English
Next Day Disclosure Return Transaction in Own Shares	2026-01-12	English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF SIMCERE ZAIMING PHARMACEUTICAL CO., LTD. ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED M&A Activity	2026-01-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Regulatory Filings	2026-01-06	English